120 related articles for article (PubMed ID: 7717616)
1. Positron emission tomography in the evaluation of laryngeal carcinoma.
McGuirt WF; Greven KM; Keyes JW; Williams DW; Watson NE; Geisinger KR; Cappellari JO
Ann Otol Rhinol Laryngol; 1995 Apr; 104(4 Pt 1):274-8. PubMed ID: 7717616
[TBL] [Abstract][Full Text] [Related]
2. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
3. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
[TBL] [Abstract][Full Text] [Related]
4. [Positron emission tomography with F-18-FDG: a new tool in the evaluation of patients with head and neck tumors].
García Velloso MJ; Quesada J; Martí JM; Azinovic I; Peñuelas I; Alcalde J; Richter JA
An Sist Sanit Navar; 1999; 22(2):155-65. PubMed ID: 12886344
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of laryngeal carcinoma before therapy: value of computed tomography and magnetic resonance tomography].
Bohndorf K
Strahlenther Onkol; 1991 Apr; 167(4):239-43. PubMed ID: 2028402
[TBL] [Abstract][Full Text] [Related]
6. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?
Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Case LD
Cancer J Sci Am; 1997; 3(6):353-7. PubMed ID: 9403048
[TBL] [Abstract][Full Text] [Related]
7. [Value of (18)F-FDG PET/CT in the diagnosis of laryngeal carcinoma].
Lv Y; Zheng H; Wang Q; Wu H; Li H; Zhou W; Tian Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Oct; 32(10):1486-90. PubMed ID: 23076191
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography of the larynx: correlation with anatomic and pathologic studies in cases of laryngeal carcinoma.
Mafee MF; Schild JA; Valvassori GE; Capek V
Radiology; 1983 Apr; 147(1):123-8. PubMed ID: 6828716
[TBL] [Abstract][Full Text] [Related]
9. [Magnetic resonance imaging of the larynx. Its contribution compared to x-ray computed tomography in the pre-therapeutic evaluation of cancers of the larynx. Apropos of 90 surgical cases].
Giron J; Joffre P; Serres-Cousiné O; Castan P; Senac JP
Ann Radiol (Paris); 1990; 33(3):170-84. PubMed ID: 2275520
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
[TBL] [Abstract][Full Text] [Related]
12. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
Lai CH; Huang KG; See LC; Yen TC; Tsai CS; Chang TC; Chou HH; Ng KK; Hsueh S; Hong JH
Cancer; 2004 Feb; 100(3):544-52. PubMed ID: 14745871
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography in patients with laryngeal carcinoma: a clinical perspective.
Werber JL; Lucente FE
Ann Otol Rhinol Laryngol; 1989 Jan; 98(1 Pt 1):55-8. PubMed ID: 2910190
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.
Gordin A; Daitzchman M; Doweck I; Yefremov N; Golz A; Keidar Z; Bar-Shalom R; Kuten A; Israel O
Laryngoscope; 2006 Feb; 116(2):273-8. PubMed ID: 16467718
[TBL] [Abstract][Full Text] [Related]
15. CT and MR evaluation of laryngeal carcinomas.
Giron J; Joffre P; Serres-Cousine O; Senac JP
J Otolaryngol; 1993 Aug; 22(4):284-93. PubMed ID: 8230380
[TBL] [Abstract][Full Text] [Related]
16. Utility of positron-emission tomography/computed tomography imaging in the management of the neck in recurrent laryngeal cancer.
Gilbert MR; Branstetter BF; Kim S
Laryngoscope; 2012 Apr; 122(4):821-5. PubMed ID: 22344673
[TBL] [Abstract][Full Text] [Related]
17. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
18. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
Lowe VJ; Kim H; Boyd JH; Eisenbeis JF; Dunphy FR; Fletcher JW
Radiology; 1999 Sep; 212(3):799-802. PubMed ID: 10478249
[TBL] [Abstract][Full Text] [Related]
19. Pre-therapeutic evaluation of laryngeal carcinomas using computed tomography and magnetic resonance imaging.
Giron J; Joffre P; Serres-Cousine O; Bonafe A; Senac JP
Isr J Med Sci; 1992; 28(3-4):225-32. PubMed ID: 1592593
[TBL] [Abstract][Full Text] [Related]
20. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
